{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:24:32Z","timestamp":1772205872346,"version":"3.50.1"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0218444","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T13:30:37Z","timestamp":1563456637000},"page":"e0218444","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+\/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7659-2968","authenticated-orcid":true,"given":"Alessandra","family":"Trojani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Pungolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Dal Molin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Lodola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariella","family":"D\u2019Adda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Perego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Elena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Turrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenza","family":"Borin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Bucelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Malato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Spina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Latargia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Artale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierangelo","family":"Spedini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Anghilieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Di Camillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Baruzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"De Canal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4401-0812","authenticated-orcid":true,"given":"Alessandra","family":"Iurlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica","family":"Morra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Cairoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,7,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s13238-015-0143-7","article-title":"Leukemia stem cells: the root of chronic myeloid leukemia","volume":"6","author":"H Zhou","year":"2015","journal-title":"Protein Cell"},{"key":"ref2","first-page":"277","article-title":"Mechanisms of resistance to BCR\u2013ABL TKIs and the therapeutic strategies: A review Critical Reviews in Oncology\/Hematology","volume":"93","author":"K Yang","year":"2015"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/MD.0000000000004765","article-title":"Cancer stem cell signaling pathways","volume":"95","author":"WH Matsui","year":"2016","journal-title":"Send to Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","article-title":"The chronic myeloid leukemia stem cell: stemming the tide of persistence","volume":"129","author":"TL Holyoake","year":"2017","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"A Quint\u00e1s-Cardama","year":"2009","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1158\/0008-5472.CAN-08-1101","article-title":"BCR\/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair","volume":"68","author":"K Cramer","year":"2008","journal-title":"Cancer Res"},{"key":"ref7","first-page":"1","article-title":"Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia","volume":"14","author":"A Wang","year":"2018","journal-title":"Hematology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.febslet.2005.12.051","article-title":"The A-loop, a novel conserved aromatic acid subdomain upstream of the Walker A motif in ABC transporters, is critical for ATP binding","volume":"580","author":"SV Ambudkar","year":"2006","journal-title":"FEBS Lett"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/leu.2014.38","article-title":"The clinical significance of ABCC3 as an imatinib transporter in chronic myeloid leukaemia","volume":"28","author":"A Giannoudis","year":"2014","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3390\/cancers6041925","article-title":"Repositioning of tyrosine kinase inhibitors as antagonists of ATP-binding cassette transporters in anticancer drug resistance","volume":"6","author":"YJ Wang","year":"2014","journal-title":"Cancers (Basel)"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1158\/1541-7786.MCR-10-0510","article-title":"c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells","volume":"9","author":"A Porro","year":"2011","journal-title":"Mol Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1182\/blood-2013-12-545640","article-title":"at al. JAK2\/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34<sup>+<\/sup> cells in vitro and in vivo","volume":"124","author":"P Gallipoli","year":"2014","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jnci\/djt006","article-title":"Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex","volume":"105","author":"M Chen","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"ref14","first-page":"30385","article-title":"Differential genomics and transcriptomics between tyrosine kinase inhibitor-sensitive and -resistant BCR-ABL-dependent chronic myeloid leukemia","volume":"13","author":"N Singh","journal-title":"Oncotarget. 2018"},{"key":"ref15","first-page":"2942","article-title":"Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinib","volume":"6","author":"S Avil\u00e9s-V\u00e1zquez","journal-title":"Cancer Med. 2017"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/sctm.17-0175","article-title":"Concise Review: Chronic myeloid leukemia: stem cell niche and response to pharmacologic treatment","volume":"7","author":"E Arrigoni","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1002\/ajh.25106","article-title":"Nilotinib induced bone marrow CD34+\/lin-Ph+ cells early clearance in newly diagnosed CP-chronic myeloid leukemia","volume":"93","author":"E Pungolino","year":"2018","journal-title":"Am J Hematol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3233\/CBM-170209","article-title":"Wide-transcriptome analysis and cellularity of bone marrow CD34+\/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment","volume":"21","author":"A Trojani","year":"2017","journal-title":"Cancer Biomark"},{"key":"ref19","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2017. Available from URL <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.R-project.org\/\" xlink:type=\"simple\">http:\/\/www.R-project.org\/<\/ext-link>."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gng015","article-title":"Summaries of Affymetrix GeneChip probe level data","volume":"31","author":"RA Irizarry","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1093\/bioinformatics\/btq431","article-title":"A Framework for Oligonucleotide Microarray Preprocessing","volume":"26","author":"BS Carvalho","year":"2010","journal-title":"Bioinformatics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray data using empirical bayes methods","volume":"8","author":"WE Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"ref23","unstructured":"Leek JT, Johnson WE, Parker HS, Fertig EJ, Jaffe AE, Storey JD, et al. 2018. sva: Surrogate Variable Analysis. R package version 3.22.0."},{"key":"ref24","unstructured":"Bolstad B (2018). preprocessCore: A collection of pre-processing functions. R package version 1.36.0."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"98","author":"V Tusher","year":"2001","journal-title":"PNAS"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the first discovery rate: a practical and powerful approach to multiple testing","volume":"57","year":"1995","journal-title":"Journal of the Royal Statistical Society"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources","volume":"4","author":"DW Huang","year":"2009","journal-title":"Nature Protoc"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"DW Huang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/1467-9868.00346","article-title":"direct approach to false discovery rates","volume":"3","author":"A Storey JD","year":"2002","journal-title":"J R Stat Soc"},{"key":"ref30","first-page":"49","article-title":"Management of chronic myeloid leukemia patients resistant to tyrosine kinase inhibitors treatment","volume":"10","author":"A Wieczorek","year":"2015","journal-title":"Biomark Insights"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/bph.12183","article-title":"Targeting survival pathways in chronic myeloid leukaemia stem cells","volume":"169","author":"A Sinclair","year":"2013","journal-title":"Br J Pharmacol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"21758","DOI":"10.18632\/oncotarget.24938","article-title":"Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients","volume":"9","author":"MR Ricciardi","year":"2018","journal-title":"Oncotarget"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/gb-2009-10-3-214","article-title":"The origin recognition complex protein family","volume":"10","author":"BP Duncker","year":"2009","journal-title":"Genome Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccr.2010.03.011","article-title":"Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate","volume":"17","author":"B Zhang","year":"2010","journal-title":"Cancer Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1158\/1078-0432.CCR-14-1290","article-title":"Selective inhibition of HDAC1 and HDAC2 as a potential therapeutic option for B-ALL","volume":"21","author":"MC Stubbs","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1158\/1078-0432.CCR-11-1971","article-title":"Cyclin-dependent kinase 7\/9 inhibitor SNS-032 abrogates FIP1-like-1 platelet-derived growth factor receptor \u03b1 and bcr-abl oncogene addiction in malignant hematologic cells","volume":"A","author":"Y Wu","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1010428317713394","DOI":"10.1177\/1010428317713394","article-title":"Deregulated expression of Cdc6 as BCR\/ABL-dependent survival factor in chronic myeloid leukemia cells","volume":"39","author":"JH Zhang","year":"2017","journal-title":"Tumour Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","article-title":"E. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development","volume":"20","author":"D Reynaud","year":"2011","journal-title":"Cancer Cell"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1101\/gad.827500","article-title":"Bub3 gene disruption in mice reveals essential mitotic spindle checkpoint function during earl embryogenesis","volume":"14","author":"P Kalitsis","year":"2000","journal-title":"Genes Dev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/1078-0432.CCR-05-0903","article-title":"Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability","volume":"12","author":"B Yuan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/path.1324","article-title":"Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer-association with tumour cell proliferation","volume":"200","author":"H Grabsch","year":"2003","journal-title":"J Pathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1111\/j.1742-4658.2011.08235.x","article-title":"Multidrug resistance proteins (MRPs\/ABCCs) in cancer chemotherapy and genetic diseases","volume":"278","author":"Z-S Chen","year":"2011","journal-title":"FEBS J"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e0161470","DOI":"10.1371\/journal.pone.0161470","article-title":"ABCB1 overexpression is a key initiator of resistance to tyrosine kinase inhibitors in CML cell lines","volume":"11","author":"LN Eadie","year":"2016","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.leukres.2009.11.004","article-title":"Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines","volume":"34","author":"DS Marques","year":"2010","journal-title":"Leuk Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"88021","DOI":"10.18632\/oncotarget.21406","article-title":"The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia","volume":"8","author":"S Galimberti","year":"2017","journal-title":"Oncotarget"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e7520","DOI":"10.1371\/journal.pone.0007520","article-title":"Imatinib and Nilotinib Reverse Multidrug Resistance in Cancer Cells by Inhibiting the Efflux Activity of the MRP7 (ABCC10)","volume":"4","author":"T Shen","year":"2009","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.18632\/oncotarget.2353","article-title":"Selective JAK2\/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem\/progenitor cells","volume":"5","author":"H Lin","year":"2014","journal-title":"Oncotarget"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.exphem.2017.05.007","article-title":"Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia","volume":"53","author":"I Sloma","year":"2017","journal-title":"Exp Hematol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12185-016-2028-9","article-title":"High IL-7 levels in the bone marrow microenvironment mediate imatinib resistance and predict disease progression in chronic myeloid leukemia","volume":"104","author":"X Zhang","year":"2016","journal-title":"Int J Hematol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","article-title":"The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells","volume":"15","author":"F Seif","year":"2017","journal-title":"Cell Commun Signal"},{"key":"ref51","first-page":"29","article-title":"Canonical and non-canonical aspects of JAK-STAT signaling: lessons from interferons for cytokine responses","volume":"8","author":"A Majoros","journal-title":"Front Immunol. 2017"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/leu.2017.250","article-title":"SHP2 is required for BCR-ABL1-induced hematologic neoplasia","volume":"32","author":"S Gu","year":"2018","journal-title":"Leukemia"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/onc.2009.7","article-title":"Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients","volume":"28","author":"AK Samanta","year":"2009","journal-title":"Oncogene"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-8722-4-6","article-title":"BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance","volume":"4","author":"H Quentmeier","year":"2011","journal-title":"J Hematol Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0218444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T00:58:00Z","timestamp":1721523480000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0218444"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Bertolini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,18]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0218444","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.17504\/protocols.io.yncfvaw","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,18]]}}}